1) Pfizer to market off-patent medicines in Philippines. Pfizer Parke Davis, a new unit will be launching nine generic medicines in Anti-infective, Hypertension and vertigo. (Philstar)
2) Zafirlukast: DRL ANDA does not infringe Astrazeneca’s asserted patents (law360). Paroduct and MOT patents are expired on Sep 2010.
3) Paragraph IV Litigation
Darunavir: Tibotec Vs Lupin & Mylan (on 15 Nov 2010) and in another case, Univ of Illinois has sued Mylan and Lupin for 7470506 (on 17 Nov 2010)
4) FDA Approves Shire plc’s Vyvanse(R) (lisdexamfetamine dimesylate) Capsules CII for the Treatment of ADHD in Adolescents (Biospace)